CWC
AMED

Carolinas Wealth Consulting’s Amedisys AMED Stock Holding History

Carolinas Wealth Consulting’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10
Closed -$905 – 1038
2023
Q4 		$905 Hold
10
– – ﹤0.01% 843
2023
Q3 		$871 Hold
10
– – ﹤0.01% 847
2023
Q2 		$870 Sell
10
-2
-17% -$164 ﹤0.01% 929
2023
Q1 		$883 Buy
+12
New +$1.04K ﹤0.01% 912
2020
Q4 		– Sell
-9
Closed -$2K – 868
2020
Q3 		$2K Buy
+9
New +$2.05K ﹤0.01% 676

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Carolinas Wealth Consulting's AMED Position: Q1 2024 in Review

Carolinas Wealth Consulting sold out of Amedisys (AMED) in Q1 2024, closing a stake of 10 shares — an estimated $905 sold.

Carolinas Wealth Consulting first reported a position in AMED in Q3 2020 and held it in 5 quarters. The position peaked at $2K in Q3 2020. 283 funds tracked by Wall St. Rank hold AMED as of Q1 2024.

  • Carolinas Wealth Consulting reported no remaining Amedisys position as of Q1 2024 after selling out during the quarter.
  • Carolinas Wealth Consulting sold 10 Amedisys shares in Q1 2024, an estimated $905.
  • Carolinas Wealth Consulting first reported a position in Amedisys in Q3 2020 and held it in 5 quarters.
  • Carolinas Wealth Consulting's Amedisys position peaked at $2K in Q3 2020.
  • 283 funds tracked by Wall St. Rank held Amedisys as of Q1 2024.

Based on Carolinas Wealth Consulting's 13F filing for Q1 2024, filed 15 May 2024.